Marcello Damiani
Director/Board Member bij BENEVOLENTAI
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Francois Nader | M | 67 | 5 jaar | |
| Shannon Klinger | M | 53 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 3 jaar |
| Elizabeth Nabel | M | 72 | 9 jaar | |
| Stéphane Bancel | M | 51 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 5 jaar |
| Avak Kahvejian | M | 48 |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 7 jaar |
| Sandra Horning | M | 75 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 4 jaar |
| Sylvain Morgeau | M | 44 | 13 jaar | |
| Lorence Kim | M | 49 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 10 jaar |
| Peter Hutt | M | 89 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 12 jaar |
| Stephen Berenson | M | 63 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 7 jaar |
| John Orloff | M | 66 | 3 jaar | |
| Fabrice Chouraqui | M | - |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 4 jaar |
| Marie-Hélène Habert-Dassault | F | 59 | 12 jaar | |
| Jean Raby | M | 60 | 2 jaar | |
| Susan Liautaud | M | - | 2 jaar | |
| Elizabeth Tallett | F | 74 | 4 jaar | |
| Stephen Hoge | M | 48 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
| Paul Sagan | M | 65 | 6 jaar | |
| Saqib Islam | M | 54 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 8 jaar |
| Harold Y. H. Boël | M | 59 | 12 jaar | |
| James Collins | M | 58 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 7 jaar |
| Ivan Griffin | M | 48 | 11 jaar | |
| Nigel Shadbolt | M | 68 | 4 jaar | |
| Olivier Brandicourt | M | 68 | 2 jaar | |
| William Scrimshaw | M | - | 5 jaar | |
| Noubar Afeyan | M | 60 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 7 jaar |
| Charbel Haber | M | - | 4 jaar | |
| Jack Szostak | M | - |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
| Catherine Tucker | F | - | 5 jaar | |
| Constantinos Neophytou | M | - | 4 jaar | |
| Fleur Wood | F | - | - | |
| Milind Kamkolkar | M | - |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | - |
| Christina Busmalis | F | - | 1 jaar | |
| José M. Vega | M | - | 3 jaar | |
| Jacqueline Miller | M | - | 4 jaar | |
| Patrick Norman Bergstedt | M | - | 4 jaar | |
| Melanie Ivarsson | M | - | 4 jaar | |
| Tracey Franklin | F | 44 | 5 jaar | |
| Anne Phelan | M | 59 | 5 jaar | |
| Gregory Moore | M | 59 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 1 jaar |
| Carl Decicco | M | 62 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | - |
| John Lepore | M | - | 4 jaar | |
| Ian Estepan | M | 48 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 3 jaar |
| Catherine Isted | F | - | 1 jaar | |
| Kate Cronin | F | 58 | 3 jaar | |
| Lavina A. Talukdar | F | - | 5 jaar | |
| Anna Fullerton Batten | F | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Philippe Gillet | M | 66 | - | |
| Agnès Lemarchand | F | 69 | 9 jaar | |
| Henri Thomasson | M | - | 28 jaar | |
| Israel Ruiz | M | 52 | - | |
| Michel Angé | M | 84 | - | |
| Joanna Shields | F | 62 | 5 jaar | |
| Claire Giraut | F | 67 | 5 jaar | |
| Moncef Slaoui | M | 64 | 3 jaar | |
| Jim Kasinger | M | 52 | 3 jaar | |
| Juan Andres | M | 59 | 6 jaar | |
| Gentiane Gorlier | M | - | 7 jaar | |
| Lori M. Henderson | F | 62 | 3 jaar | |
| Cristina Rondinone | M | 64 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 1 jaar |
| Jennifer Ling Lee | F | 61 | - | |
| Tal Zaks | M | 58 | 6 jaar | |
| Corinne Le Goff | M | 58 | 1 jaar | |
| Poorya Hosseini | M | - |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | 4 jaar |
| Georges Hibon | M | 86 | 10 jaar | |
| Jason Glashow | M | - | - | |
| Richard J. Wanstall | M | 55 | 4 jaar | |
| Colleen Hussey | F | - | - | |
| Giuseppe Ciaramella | M | 55 | 4 jaar | |
| Francine Gregoire | M | 63 | 3 jaar | |
| Matthew Stanton | M | 51 | 3 jaar | |
| Sandrine Flory | F | - | 6 jaar | |
| Lee Cooper | M | - | 2 jaar | |
| Michael Mullette | M | - | 2 jaar | |
| Daniel Neil | M | - | 7 jaar | |
| Barry Ticho | M | 64 | 1 jaar | |
| Raymond C. Jordan | M | 70 | - | |
| Paul Burton | M | 55 | 2 jaar | |
| Christian Brechot | M | 71 | 4 jaar | |
| Eileen C. Pruette | F | 65 | 2 jaar | |
| Anne Drapeau | F | 58 | 3 jaar | |
| Manuel Méndez Muñiz | M | 56 | 4 jaar | |
| Megan E. Pace | F | 51 | 2 jaar | |
| James P. Whelan | M | - | - | |
| Theodore Ashburn | M | 57 | 1 jaar | |
| Philippe Cleuziat | M | - | - | |
| David Meline | M | 66 | 2 jaar | |
| Jean-Fabien Monin | M | 54 | 3 jaar | |
| Mark Miller | M | - | 12 jaar | |
| Ann Hunter | M | 68 | 7 jaar | |
| Eric Bouvier | M | 63 | 9 jaar | |
| Stephen Harbin | M | 66 | - | |
| Mojgan Lefebvre | F | 58 | 3 jaar | |
| Theo Melas-Kyriazi | M | 64 | 2 jaar | |
| Wendy S. Arnold | F | 52 | 3 jaar | |
| Nicholas Keher | M | 42 | 1 jaar | |
| Robert Dolski | M | 54 | 3 jaar | |
| Stephanie Engels | F | - | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 60 | 61.22% |
| Frankrijk | 21 | 21.43% |
| Verenigd Koninkrijk | 19 | 19.39% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Marcello Damiani
- Persoonlijk netwerk
